Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV1 for COPD in Chinese Population - a Prospective Cohort Study

NCT03532893 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT03532893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03532893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV1 for COPD in Chinese Population - a Prospective Cohort Study
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Completed
Start date
March 3, 2018
Completion date
October 9, 2021
Enrollment
10,385 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

copd, fev1